within Pharmacolibrary.Drugs.S_SensoryOrgans.S01L_OcularVascularDisorderAgents.S01LA05_Aflibercept;

model Aflibercept
  extends Pharmacolibrary.Drugs.ATC.S.S01LA05;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>S01LA05</td></tr><td>route:</td><td>intravitreal</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Aflibercept is a recombinant fusion protein that acts as a vascular endothelial growth factor (VEGF) inhibitor, used primarily for the treatment of neovascular (wet) age-related macular degeneration (AMD), diabetic macular edema, and other retinal vascular diseases. It is approved for intravitreal use in ophthalmology.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters after a single intravitreal injection of aflibercept 2 mg in adult patients with neovascular AMD; population includes both sexes, typically age >50 years.</p><h4>References</h4><ol><li><p>Avery, RL, et al., &amp; Hanley, WD (2017). SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB. <i>Retina (Philadelphia, Pa.)</i> 37(10) 1847–1858. DOI:<a href=\"https://doi.org/10.1097/IAE.0000000000001493\">10.1097/IAE.0000000000001493</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/28106709/\">https://pubmed.ncbi.nlm.nih.gov/28106709</a></p></li><li><p>Park, SJ, et al., &amp; Woo, SJ (2016). Intraocular Pharmacokinetics of Intravitreal Aflibercept (Eylea) in a Rabbit Model. <i>Investigative ophthalmology &amp; visual science</i> 57(6) 2612–2617. DOI:<a href=\"https://doi.org/10.1167/iovs.16-19204\">10.1167/iovs.16-19204</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27258433/\">https://pubmed.ncbi.nlm.nih.gov/27258433</a></p></li><li><p>García-Quintanilla, L, et al., &amp; Fernández-Ferreiro, A (2019). Pharmacokinetics of Intravitreal Anti-VEGF Drugs in Age-Related Macular Degeneration. <i>Pharmaceutics</i> 11(8) –. DOI:<a href=\"https://doi.org/10.3390/pharmaceutics11080365\">10.3390/pharmaceutics11080365</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31370346/\">https://pubmed.ncbi.nlm.nih.gov/31370346</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Aflibercept;
